Article

Importance of Rare Disease Awareness Highlights SPT Week in Review

Author(s):

Top news of the week from Specialty Pharmacy Times.

5. Exposure to Diesel Exhaust May Increase Risk of Amyotrophic Lateral Sclerosis

Men exposed to diesel exhaust at work may increase their risk of ALS by at least 20%. Read more.

4. Registration Open for the 2018 NASP Annual Meeting

The sixth annual National Association of Specialty Pharmacy meeting features numerous educational sessions and networking opportunities for specialty pharmacy stakeholders. Read more.

3. FDA Expands Abemaciclib Indication as Initial Therapy for Advanced Breast Cancer

The FDA previously approved abemaciclib for use in combination with fulvestrant in women with HR+/HER2- advanced breast cancer with disease progression following endocrine therapy. Read more.

2. FDA Introduces New Options for Patients in Observance of Rare Disease Day

Several new approaches may increase drug development efforts for rare diseases. Read more.

1. How Specialty Pharmacies Support 30 Million Americans on Rare Disease Day and Beyond

Specialty pharmacies must focus on the fundamentals of compassion and effective communication to offer the patient-centric support needed for patients with a rare disease. Read more.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards